
Rahul Mehan, MD, explains why patients are pushing back on daily BPH medication, how prostate anatomy shapes the choice between mechanical, thermal, and drug-coated therapies, and what's fueling the shift to office-based care.

Rahul Mehan, MD, explains why patients are pushing back on daily BPH medication, how prostate anatomy shapes the choice between mechanical, thermal, and drug-coated therapies, and what's fueling the shift to office-based care.

Two years into offering drug-coated balloon dilation for BPH, Rahul Mehan, MD, compares his outcomes with the PINNACLE trial (NCT04131907), walks through sizing and patient selection, and details the recovery and safety counseling patients need before treatment.

Rahul Mehan, MD, explains when traditional resective procedures still make more sense than office-based options, shares his top advice for urologists early in adoption, and previews the minimally invasive technologies he's watching next.